How effective is meningococcal vaccination for meningococcal disease?

Meningococcal disease is caused by Neisseria meningitidis and may involve the membranes around the brain and spinal cord or the bloodstream. Vaccines are made to target selected groups, or strains, of this bacterium. A product can therefore protect against the strains it covers without covering every meningococcal strain.

The vaccine prepares immune defences before exposure. It cannot clear an infection that is already developing, and it does not protect against unrelated causes of meningitis. Age, immune health, travel, outbreak conditions, previous doses, and the vaccine product all influence the advice given.

Discuss vaccination with a clinician and bring any available immunisation record. Mention immune-system problems, medicines, pregnancy, allergies, and travel plans so the recommended product and timing can be checked.

Keep the vaccination record and follow advice about further doses. If you have been in close contact with someone diagnosed with meningococcal disease, contact health services promptly because preventive medicine may be considered separately from vaccination.

Call emergency services for sudden fever, severe headache, stiff neck, confusion, marked drowsiness, seizures, breathing difficulty, or a dark or non-fading rash. Meningococcal disease can worsen quickly, so do not wait for every symptom or rely on prior vaccination.

Ask which strain groups the vaccine covers, whether your previous doses count, whether another dose is advised, and which reactions are expected. If exposure has occurred, ask specifically about urgent assessment, testing, and preventive medicine for close contacts.